Prothena Corporation plc Live Stock Price Today, Share Analysis and Chart

Name: Prothena Corporation plc: Is Infosys Ltd. worth buying?
Item: Prothena Corporation plc
Rating: 1.38525
Author: Trendlyne DVM scores

about

Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseas...

8.18 0.12 (1.49%)

63.50% Fall from 52W High

459.0K

XNAS Volume

XNAS 18 Sep, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

16.0 / 100

Technically Neutral

39.4 / 100

1Yr Price target upside is 47%

6 analysts

Prothena Corporation plc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Prothena Corporation plc Live Stock Price Today, Share Analysis and Chart

Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseas...

63.50% Fall from 52W High

SWOT Analysis

Prothena Corporation plc Live Price Chart